RSS-Feed abonnieren
DOI: 10.3414/ME13-01-0088
Combining Cross-sectional Data on Prevalence with Risk Estimates from a Prediction Model
A Novel Method for Estimating the Attributable RiskPublikationsverlauf
received:08. August 2013
accepted:10. April 2014
Publikationsdatum:
20. Januar 2018 (online)
Summary
Objectives: Estimation of the attributable risk for fatal diseases by combining two different data sources.
Methods: We derive a method to estimate the attributable risks of different risk factors by combining general mortality risks with upto-date prevalences of the risk factors using estimates from a risk prediction model and cross-sectional data of a cohort study. Partial attributable risks have been used to illustrate the proportions of the different risk factors for the attributable risk. In addition we derive standard errors for the attributable risk based on the Taylor series expansion. Since the data of our cohort study was sampled with the same size in each 10 years age stratum which does not reflect the age-structure of the general population, the attributable risk and its standard errors are calculated using an approach that allows the weighting of the data according to population proportions of age. The formula for the standard errors has been evaluated using bootstrap-techniques.
Results: We successfully implemented the method for the estimation of the attributable risk and its standard errors by integrating risk information using data of the HeartScore Germany and cross-sectional data emerging from the Gutenberg Health Study. The attributable risk can now be calculated without using the information of the overall disease rate. The bootstrap method shows, that the formula for the standard errors is useful.
Conclusion: Our method allows for the combination of different data sources in order to estimate attributable risks and our formula for the standard errors seems to yield a good approximation. But the validity of our method highly depends on the validity of the underlying data sources.
-
References
- 1 Gaber E. Gesundheitsberichterstattung des Bundes. 52nd ed. Robert-Koch-Institut. Berlin: Statistisches Bundesamt; 2011
- 2 Stamler J, Neaton JD, Garside DB, Daviglus ML. Current status: six established major risk factors - and low risk. In Marmot M, Elliott P. editors Coronary Heart Disease Epidemiology: From aetiology to public health 2nd ed.. New York: Oxford University Press Inc.; 2005: 32-70.
- 3 The International Consortium for Blood Pressure Genome-Wide Association Studies Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk. Nature 2011; 478: 103-109.
- 4 Schulte H, Assmann G, Cullen P. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study. Circulation 2002; 105 (03) 310-315.
- 5 Keil U, Fitzgerald AP, Gohlke H, Wellmann J, Hense HW. Risikoabschätzung tödlicher Herz-Kreislauf-Erkrankungen. Deutsches Ärzteblatt 2005; 102 (25) A1808-12.
- 6 Wilson PWF, D´Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation 1998; 97: 1837-1847.
- 7 Chang M, Hahn RA, Teutsch SM, Hutwagner LC. Multiple risk factors and population attributable risk for ischemic heart disease mortality in the United States 1971-1992. Journal of Clinical Epidemiology 2001; 54 (06) 634-644.
- 8 Reissigová J, Zvárová J. The Framingham risk function underestimated absolute coronary heart disease risk in Czech men. Methods Inf Med 2007; 46 (01) 43-49.
- 9 Hozawa A. Attributable fractions of risk factors of cardiovascular diseases. Journal of Epidemiology 2011; 21 (02) 81-86.
- 10 Yusuf S, Hawken S, Öunpuu S, Dans T, Avezum A, Lanas F. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries. The Lancet 2004; 364: 937-952.
- 11 Ramroth H, Dietz A, Becher H. Interaction effects and population-attributable risks for smoking and alcohol on laryngeal cancer and its subsites. A case-control study from Germany. Methods Inf Med 2004; 43 (05) 499-504.
- 12 Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 1953; 9 (03) 531-541.
- 13 Miettinen OS. Proportion of Disease caused or prevented by a given exposure, trait or intervention. American Journal of Epidemiology 1973; 99 (05) 325-332.
- 14 Blankenberg S, Wild PS, Zeller T, Blettner M, Dugi KA, Lackner KJ. et al. Die Gutenberg Gesundheitsstudie. Bundesgesundheitsblatt 2012. Gesundheitsschutz 6/7 824-830.
- 15 Whitemore AS. Statistical methods for estimating attributable risks from retrospective data. Stat Med 1982; 1 (03) 229-243.
- 16 Shapley LS. Contributions to the theory of games II. Tucker AW, Kuhn HW. editors New Jersey: Press Princeton University; 1953
- 17 Gefeller O, Eide GE. Sequential and average attributable fractions as aids in the selection of preventive strategies. J Clin Epidemiol 1995; 48 (05) 645-655.
- 18 Rabe C, Gefeller O. The Attributable Risk in a Multifactorial Situation: Evaluation of Different Methods of Partitioning. Methods Inf Med 2006; 45 (04) 404-408.
- 19 Land M, Vogel C, Gefeller O. Partitioning methods for multifactorial risk attribution. Statistical Methods in Medical Research 2001; 10 (03) 217-230.
- 20 Ezzati M, Hoorn SV, Rodgers A, Lopez AD, Mathers CD, Murray CJL. et al. Estimates of global and regional potential health gains from reducing multiple major risk factors. The Lancet 2003; 362 9380 271-280.
- 21 Lopez AD. The evolution of the Global Burden of Disease framework for disease, injury and risk factor quantification: developing the evidence base for national, regional and global public health action. Global Health 2005; 1 (01) 5
- 22 Gefeller O. An Annotated Bibliography on the Attributable Risk. Biometrical Journal 1992; 34 (08) 1007-1012.
- 23 Armitage P, Colton T. editors Encyclopedia of Biostatistics, New York: John Wiley & Sons; 2005
- 24 Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G. et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European Heart Journal 2003; 24: 987-1003.
- 25 Federal Environment Agency (Germany), Federal Institute for Drugs and Medical Devices (Germany), Max Planck Institute of Psychiatry, Robert Koch Institute Germany National Health Interview and Examination Survey 1997-1999. Berlin, Germany: Robert Koch Institute; 2000
- 26 Bellach B-M. Editorial: Der Bundes-Gesundheitssurvey 1998- Erfahrungen, Ergebnisse, Perspektiven. Gesundheitswesen 61 (Sonderheft 2) Stuttgart: Thieme; 1999: 55-56.
- 27 Keil U, Fitzgerald AP, Gohlke H, Wellmann J, Hense HW. Risikoabschätzung tödlicher Herz-Kreislauf-Erkrankungen - Methoden. Deutsches Ärzteblatt 2005; 102 (25) A1-2.
- 28 Law MR, Rodgers A. Lipids and cholesterol. In: Elliott P, Marmot M. editors Coronary Heart Disease Epidemiology: From aetiology to public health 2nd ed.. New York: Oxford University Press Inc.; 2005: 174-86.